Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 7919504 Thiadiazole modulators of PKB

Patent 7919504 was granted and assigned to Amgen on April, 2011 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Qingping Zeng0

Qingyian Liu0

Seifu Tadesse0

Xianghong Wang0

Xin Huang0

John G. Allen0

Andreas Reichelt0

Celia Dominguez0

...

Date of Patent

April 5, 2011

0

Patent Application Number

122185230

Date Filed

July 15, 2008

0

Patent Citations Received

US Patent 11905281 KRAS G12C inhibitors and methods of using the same

0

US Patent 12083121 Substituted piperazines as KRAS G12C inhibitors

0

US Patent 11918584 Combination therapy including a KRAS

0

US Patent 11766436 KRAS G12C inhibitors and methods of using the same

US Patent 11993597 Inhibitors of KRAS G12C and methods of using the same

0

Patent Primary Examiner

0

Patent abstract

The invention relates to thiazole compounds of Formula I and Formula II and compositions thereof useful for treating diseases mediated by protein kinase B (PKB) where the variables have the definitions provided herein.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7919504 Thiadiazole modulators of PKB

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool